Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Ise

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|May 2, 2003
p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 geneHiroto Izumi, Ryo Ohta, Gunji Nagatani, et al.
Cancer Research|December 26, 2003
Activating transcription factor 4 increases the cisplatin resistance of human cancer cell linesMizuho Tanabe, Hiroto Izumi, Tomoko Ise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2013
Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptorsAndrea Franco, Bazarragchaa Damdinsuren, Tomoko Ise, et al.
Antibody Therapeutics|October 2, 2018
Preclinical development of anti-BCMA immunotoxins targeting multiple myelomaZoe Shancer, Matthew Williams, Austin Igelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodiesTomoko Ise, Hiroshi Maeda, Kenneth Santora, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2005
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapySatoshi Nagata, Tomoko Ise, Masanori Onda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitisBenjamin Terrier, Satoshi Nagata, Tomoko Ise, et al.
Antibody Therapeutics|February 17, 2025
Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 moleculeHiroki Akiba, Tomoko Ise, Reiko Satoh, et al.
Biochemical and Biophysical Research Communications|April 24, 2024
Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumabRisa Asano, Makoto Nakakido, Jorge Fernández Pérez, et al.
The Journal of Biological Chemistry|June 25, 2002
p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expressionHidetaka Uramoto, Hiroto Izumi, Tomoko Ise, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|May 2, 2003
p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 geneHiroto Izumi, Ryo Ohta, Gunji Nagatani, et al.
Cancer Research|December 26, 2003
Activating transcription factor 4 increases the cisplatin resistance of human cancer cell linesMizuho Tanabe, Hiroto Izumi, Tomoko Ise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2013
Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptorsAndrea Franco, Bazarragchaa Damdinsuren, Tomoko Ise, et al.
Antibody Therapeutics|October 2, 2018
Preclinical development of anti-BCMA immunotoxins targeting multiple myelomaZoe Shancer, Matthew Williams, Austin Igelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodiesTomoko Ise, Hiroshi Maeda, Kenneth Santora, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2005
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapySatoshi Nagata, Tomoko Ise, Masanori Onda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitisBenjamin Terrier, Satoshi Nagata, Tomoko Ise, et al.
Antibody Therapeutics|February 17, 2025
Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 moleculeHiroki Akiba, Tomoko Ise, Reiko Satoh, et al.
Biochemical and Biophysical Research Communications|April 24, 2024
Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumabRisa Asano, Makoto Nakakido, Jorge Fernández Pérez, et al.
The Journal of Biological Chemistry|June 25, 2002
p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expressionHidetaka Uramoto, Hiroto Izumi, Tomoko Ise, et al.
Pageof 4